Companies: 10,795·Total market cap: $144.5T
Centuri Holdings, Inc.

Centuri Holdings, Inc.

CTRINYSEUtilities● Active
$29.84
$-1.37(-4.39%)
Market Cap$3.0B
P/E Ratio
52W High$42.985
52W Low$19.04

Centuri Holdings, Inc. (CTRI) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

ctri · stock forecast · 6 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 6 Wall Street analysts in the past 3 months

SellBuy

Buy

6 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
3
Hold
1
Sell
2
Strong Sell
0
Total: 6 · Buy rate: 50.0%

12-Month Price Target

High

$41.00

Consensus

$35.25

+18.1% upside

Low

$30.00

Median: $35 · Last Close: $29.84

The Centuri Holdings, Inc. (CTRI) analyst consensus is Buy, based on ratings from 6 Wall Street analysts over the past 3 months. The average 12-month CTRI price target is $35.25, representing +18.1% upside from the current price of $29.84.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $35 (18.1%)

Consensus Target

$35.25

18.1% upside

High Target

$41

37.4%

Low Target

$30

0.5%

Current Price

$29.84

as of today

Based on analyst price targets, the CTRI stock price prediction for the next 12 months ranges from $30 to $41. The consensus CTRI price forecast of $35.25 implies 18.1% upside from the current price of $29.84.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$29.511.12%

1-day model range: $29.25–$29.76. Peak: $29.76 (-1.12%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$45+51.6%
2028$59+98.5%
2029$70+135.4%
2030$78+161.6%
2031+179.1%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

14%7%79%
2Buy
1Neutral
11Sell
RSI (14)41.8Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · CTRI · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$30.47SELL
MA 10$30.63SELL
MA 20$31.01SELL
MA 50$32.62SELL
MA 100$31.08SELL
MA 200$26.72BUY
Current $CTRI · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$30.45SELL
EMA 10$30.67SELL
EMA 20$31.37SELL
EMA 50$31.84SELL
EMA 100$30.58SELL
EMA 200$27.94BUY
Current $CTRI · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
UBS2026-05-11
Maintains
NeutralNeutral
Cantor Fitzgerald2026-05-11
Maintains
OverweightOverweight
JP Morgan2026-05-08
Maintains
UnderweightUnderweight
Wells Fargo2026-05-08
Maintains
OverweightOverweight
Wells Fargo2026-04-01
Maintains
OverweightOverweight
Cantor Fitzgerald2026-03-25
Maintains
OverweightOverweight
Cantor Fitzgerald2026-02-27
Maintains
OverweightOverweight
Wells Fargo2026-02-26
Maintains
OverweightOverweight
Wells Fargo2026-01-07
Maintains
OverweightOverweight
UBS2025-11-13
Maintains
NeutralNeutral

Wall Street analysts have recently issued updated ratings on Centuri Holdings, Inc. (CTRI) stock. Of the recent 25 rating actions, 0 were upgrades and 2 were downgrades. 6 analysts currently cover CTRI.

Analyst Recommendation Trends

Buy ratings02↑ +2
Hold ratings11
Sell ratings11

CTRI analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 2 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$3.5B

↓ 15.2% YoY

Revenue Next Year

$3.8B

↑ 9.7% YoY

EPS This Year

$0.72

EPS Next Year

$1.03

↑ 41.9% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast CTRI EPS of $0.72 for the current fiscal year, based on estimates from 5 analysts. The CTRI revenue forecast is $3.5B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The CTRI stock forecast is supported by two independent data sources: analyst consensus ratings from 6 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CTRI price target is $35.25 (+18.1% upside), with an analyst consensus of Buy.

The CTRI short-term stock prediction for tomorrow is $29.51 (-1.12%). The CTRI stock price prediction for 2027 estimates an average of $45. The CTRI stock prediction for 2030 projects a range of $71–$85.

Centuri Holdings, Inc. trades on NYSE under the ticker CTRI. The CTRI stock outlook for 2027 is broadly positive, supported by a Buy consensus among 50% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

CTRI forecast · 8 questions

According to 6 Wall Street analysts, the average 12-month CTRI price target is $35.25, with a high forecast of $41.00 and a low of $30.00. The median price target is shown in the chart above when available. This implies +18.1% potential upside from the current price of $29.84.

CTRI price targetWhat is CTRI price targetCTRI analyst price targetCTRI 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.